BioCentury | Nov 9, 2018
Company News

AZ looks to new medicines to drive growth

...Brand), AZD9291 (Compound #), osimertinib (Generic), Tagrisso (Other) AstraZeneca plc Merck & Co. Inc. Adrenergic receptor beta 2 (ADRB2) Corticoid receptors Epidermal...
BioCentury | Nov 8, 2018
Company News

AZ looks to new medicines to drive growth

...Brand), AZD9291 (Compound #), osimertinib (Generic), Tagrisso (Other) AstraZeneca plc Merck & Co. Inc. Adrenergic receptor beta 2 (ADRB2) Corticoid receptors Epidermal...
BioCentury | Feb 16, 2018
Clinical News

Sandoz gets CRL for generic Advair

...De Leon Adoair Advair Advair Diskus salmeterol/fluticasone propionate Seretide VR315 GlaxoSmithKline plc Hikma Pharmaceuticals plc Mylan N.V. Novartis AG Sandoz Ltd. Vectura Group plc Adrenergic receptor beta 2 (ADRB2) Corticoid receptors...
BioCentury | Feb 8, 2018
Company News

GSK breathes easier after delay for Sandoz’s generic Advair

...disease (COPD). Jaime De Leon Adoair Advair Advair Diskus AirFluSal Forspiro IrFlosol Forspiro salmeterol/fluticasone propionate Seretide VR315 GlaxoSmithKline plc Mylan N.V. Novartis AG Sandoz Ltd. Adrenergic receptor beta 2 (ADRB2) Corticoid receptors...
BioCentury | Feb 2, 2018
Clinical News

After Phase III results, AZ's COPD combo heading for submissions

...submit MAA (2019); Phase III data (2019) Jaime De Leon Bevespi Aerosphere budesonide/formoterol glycopyrronium/formoterol fumarate PT003 PT010 Symbicort AstraZeneca plc Adrenergic receptor beta 2 (ADRB2) Corticoid receptors Muscarinic...
BioCentury | Jan 26, 2018
Clinical News

After Phase III results, AZ's COPD combo heading for submissions

...approved as long-term maintenance treatment for COPD. Jaime De Leon Bevespi Aerosphere budesonide/formoterol glycopyrronium/formoterol fumarate PT003 PT010 Symbicort AstraZeneca plc Adrenergic receptor beta 2 (ADRB2) Corticoid receptors Muscarinic...
BioCentury | Oct 20, 2017
Clinical News

FDA approves Symbicort to reduce COPD exacerbations

...plc (LSE:AZN; NYSE:AZN), London, U.K. Product: Symbicort budesonide/formoterol Business: Pulmonary Meghan Sullivan budesonide/formoterol Symbicort AstraZeneca plc Adrenergic receptor beta 2 (ADRB2) Corticoid receptors...
BioCentury | Mar 17, 2017
Company News

AZ, Circassia to share rights to two COPD therapies

...Aerosphere Bretaris Genuair Brimica Genuair budesonide/formoterol Duaklir Genuair Eklira Genuair glycopyrrolate/formoterol fumarate KHK4563 KRP-AB1102F LAS34273 LAS40464 MEDI-563 PT003 Symbicort Symbicort Turbuhaler Tudorza Tudorza Genuair Tudorza Pressair AstraZeneca plc Circassia Pharmaceuticals plc Adrenergic receptor beta 2 (ADRB2) Corticoid receptors Interleukin-5...
BioCentury | Feb 1, 2017
Clinical News

Symbicort regulatory update

...LSE:AZN; NYSE:AZN), London, U.K. Product: Symbicort budesonide/ formoterol Business: Inflammation Julian Zhu budesonide/formoterol Symbicort AstraZeneca plc Adrenergic receptor beta 2 (ADRB2) Corticoid receptors...
BioCentury | Jan 27, 2017
Clinical News

Symbicort regulatory update

...plc (LSE:AZN; NYSE:AZN), London, U.K. Product: Symbicort budesonide/formoterol Business: Inflammation Julian Zhu budesonide/formoterol Symbicort AstraZeneca plc Adrenergic receptor beta 2 (ADRB2) Corticoid receptors...
Items per page:
1 - 10 of 110